Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease.

Anne M van DijkM de VriesF El-MorabitS T BacM W MundtL E van der SchuitM M C HirdesM KaraJ de BruijneS van MeerH A H KaasjagerH W de ValkF P VleggaarK J van Erpecum

Published in: Internal and emergency medicine (2023)

Both steatosis and fibrosis improve markedly in overweight/obese patients with MASLD after 6 months IGB combined with lifestyle modification. Our results warrant further research into long-term effect of IGB in these patients.

Keyphrases

weight loss
metabolic syndrome
end stage renal disease
physical activity
ejection fraction
newly diagnosed
chronic kidney disease
bariatric surgery
insulin resistance
type diabetes
peritoneal dialysis
high fat diet
patient reported outcomes
obese patients
patient reported